These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26005524)

  • 1. Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 Diabetes.
    Shah SK; He S; Guo L; Truong Q; Qi H; Du W; Lai Z; Liu J; Jian T; Hong Q; Dobbelaar P; Ye Z; Sherer E; Feng Z; Yu Y; Wong F; Samuel K; Madiera M; Karanam BV; Reddy VB; Mitelman S; Tong SX; Chicchi GG; Tsao KL; Trusca D; Feng Y; Wu M; Shao Q; Trujillo ME; Eiermann GJ; Li C; Pachanski M; Fernandez G; Nelson D; Bunting P; Morissette P; Volksdorf S; Kerr J; Zhang BB; Howard AD; Zhou YP; Pasternak A; Nargund RP; Hagmann WK
    ACS Med Chem Lett; 2015 May; 6(5):513-7. PubMed ID: 26005524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAR exploration at the C-3 position of tetrahydro-β-carboline sstr3 antagonists.
    He S; Dobbelaar PH; Guo L; Ye Z; Liu J; Jian T; Truong Q; Shah SK; Du W; Qi H; Bakshi RK; Hong Q; Dellureficio JD; Sherer E; Pasternak A; Feng Z; Reibarkh M; Lin M; Samuel K; Reddy VB; Mitelman S; Tong SX; Chicchi GG; Tsao KL; Trusca D; Wu M; Shao Q; Trujillo ME; Fernandez G; Nelson D; Bunting P; Kerr J; Fitzgerald P; Morissette P; Volksdorf S; Eiermann GJ; Li C; Zhang BB; Howard AD; Zhou YP; Nargund RP; Hagmann WK
    Bioorg Med Chem Lett; 2016 Mar; 26(6):1529-1535. PubMed ID: 26898814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of Cardiovascular Effects of Tetrahydro-β-carboline sstr3 antagonists.
    He S; Lai Z; Ye Z; Dobbelaar PH; Shah SK; Truong Q; Du W; Guo L; Liu J; Jian T; Qi H; Bakshi RK; Hong Q; Dellureficio J; Reibarkh M; Samuel K; Reddy VB; Mitelman S; Tong SX; Chicchi GG; Tsao KL; Trusca D; Wu M; Shao Q; Trujillo ME; Fernandez G; Nelson D; Bunting P; Kerr J; Fitzgerald P; Morissette P; Volksdorf S; Eiermann GJ; Li C; Zhang B; Howard AD; Zhou YP; Nargund RP; Hagmann WK
    ACS Med Chem Lett; 2014 Jul; 5(7):748-53. PubMed ID: 25050159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of Glucose-Dependent Insulin Secretion by a Potent, Selective sst3 Antagonist.
    Pasternak A; Feng Z; de Jesus R; Ye Z; He S; Dobbelaar P; Bradley SA; Chicchi GG; Tsao KL; Trusca D; Eiermann GJ; Li C; Feng Y; Wu M; Shao Q; Zhang BB; Nargund R; Mills SG; Howard AD; Yang L; Zhou YP
    ACS Med Chem Lett; 2012 Apr; 3(4):289-93. PubMed ID: 24900466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 Diabetes.
    He S; Ye Z; Truong Q; Shah S; Du W; Guo L; Dobbelaar PH; Lai Z; Liu J; Jian T; Qi H; Bakshi RK; Hong Q; Dellureficio J; Pasternak A; Feng Z; deJesus R; Yang L; Reibarkh M; Bradley SA; Holmes MA; Ball RG; Ruck RT; Huffman MA; Wong F; Samuel K; Reddy VB; Mitelman S; Tong SX; Chicchi GG; Tsao KL; Trusca D; Wu M; Shao Q; Trujillo ME; Eiermann GJ; Li C; Zhang BB; Howard AD; Zhou YP; Nargund RP; Hagmann WK
    ACS Med Chem Lett; 2012 Jun; 3(6):484-9. PubMed ID: 24900499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of highly potent and selective non-peptide antagonists of the arginine vasopressin V1A receptor by introduction of a 2-ethyl-1H-1-imidazolyl group.
    Shimada Y; Akane H; Taniguchi N; Matsuhisa A; Kawano N; Kikuchi K; Yatsu T; Tahara A; Tomura Y; Kusayama T; Wada K; Tsukada J; Tsunoda T; Tanaka A
    Chem Pharm Bull (Tokyo); 2005 Jul; 53(7):764-9. PubMed ID: 15997131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of substituted (4-phenyl-1H-imidazol-2-yl)methanamine as potent somatostatin receptor 3 agonists.
    Lai Z; He S; Sherer EC; Wu Z; Yu Y; Ball R; Hong Q; Yang DX; Guo L; Li D; Tuang Q; Chicchi GG; Trusca D; Tsao KL; Zhou YP; Howard AD; Nargund RP; Hagmann WK
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3520-5. PubMed ID: 26199120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific labelling of serotonin 5-HT(1B) receptors in rat frontal cortex with the novel, phenylpiperazine derivative, [3H]GR125,743. A pharmacological characterization.
    Millan MJ; Newman-Tancredi A; Lochon S; Touzard M; Aubry S; Audinot V
    Pharmacol Biochem Behav; 2002 Apr; 71(4):589-98. PubMed ID: 11888550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine.
    Salvatore CA; Hershey JC; Corcoran HA; Fay JF; Johnston VK; Moore EL; Mosser SD; Burgey CS; Paone DV; Shaw AW; Graham SL; Vacca JP; Williams TM; Koblan KS; Kane SA
    J Pharmacol Exp Ther; 2008 Feb; 324(2):416-21. PubMed ID: 18039958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of a Novel Binding Motif to (E)-3-(3,5-Difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)phenyl)acrylic Acid (AZD9496), a Potent and Orally Bioavailable Selective Estrogen Receptor Downregulator and Antagonist.
    De Savi C; Bradbury RH; Rabow AA; Norman RA; de Almeida C; Andrews DM; Ballard P; Buttar D; Callis RJ; Currie GS; Curwen JO; Davies CD; Donald CS; Feron LJ; Gingell H; Glossop SC; Hayter BR; Hussain S; Karoutchi G; Lamont SG; MacFaul P; Moss TA; Pearson SE; Tonge M; Walker GE; Weir HM; Wilson Z
    J Med Chem; 2015 Oct; 58(20):8128-40. PubMed ID: 26407012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Structure-Activity Relationships of Tetrahydro-β-carboline Derivatives as Anticancer and Cancer-chemopreventive Agents.
    Zhang M; Park EJ; Kondratyuk TP; Pezzuto JM; Sun D
    Anticancer Res; 2018 Aug; 38(8):4425-4433. PubMed ID: 30061206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig.
    Pullar IA; Boot JR; Broadmore RJ; Eyre TA; Cooper J; Sanger GJ; Wedley S; Mitchell SN
    Eur J Pharmacol; 2004 Jun; 493(1-3):85-93. PubMed ID: 15189767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of novel 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole triazole derivatives as potent TRPV1 antagonists.
    Li J; Nie C; Qiao Y; Hu J; Li Q; Wang Q; Pu X; Yan L; Qian H
    Eur J Med Chem; 2019 Sep; 178():433-445. PubMed ID: 31202991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of 2-(4-((1H-1,2,4-triazol-1-yl)methyl)-5-(4-bromophenyl)-1-(2-chlorophenyl)-1H-pyrazol-3-yl)-5-tert-butyl-1,3,4-thiadiazole (GCC2680) as a potent, selective and orally efficacious cannabinoid-1 receptor antagonist.
    Lee J; Seo HJ; Lee SH; Kim J; Jung ME; Lee SH; Song KS; Lee J; Kang SY; Kim MJ; Kim MS; Son EJ; Lee M; Han HK
    Bioorg Med Chem; 2010 Sep; 18(17):6377-88. PubMed ID: 20673729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of (R)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-dihydro-1H-imidazo[4,5-c]pyridin-5(4H)-yl)methanone (JNJ 54166060), a Small Molecule Antagonist of the P2X7 receptor.
    Swanson DM; Savall BM; Coe KJ; Schoetens F; Koudriakova T; Skaptason J; Wall J; Rech J; Deng X; De Angelis M; Everson A; Lord B; Wang Q; Ao H; Scott B; Sepassi K; Lovenberg TW; Carruthers NI; Bhattacharya A; Letavic MA
    J Med Chem; 2016 Sep; 59(18):8535-48. PubMed ID: 27548392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 1,3-dipropyl-8-(1-heteroarylmethyl-1H-pyrazol-4-yl)-xanthine derivatives as high affinity and selective A2B adenosine receptor antagonists.
    Elzein E; Kalla R; Li X; Perry T; Parkhill E; Palle V; Varkhedkar V; Gimbel A; Zeng D; Lustig D; Leung K; Zablocki J
    Bioorg Med Chem Lett; 2006 Jan; 16(2):302-6. PubMed ID: 16275090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists.
    Tabrizi MA; Baraldi PG; Preti D; Romagnoli R; Saponaro G; Baraldi S; Moorman AR; Zaid AN; Varani K; Borea PA
    Bioorg Med Chem; 2008 Mar; 16(5):2419-30. PubMed ID: 18077171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hit-to-Lead Optimization and Discovery of 5-((5-([1,1'-Biphenyl]-4-yl)-6-chloro-1H-benzo[d]imidazol-2-yl)oxy)-2-methylbenzoic Acid (MK-3903): A Novel Class of Benzimidazole-Based Activators of AMP-Activated Protein Kinase.
    Lan P; Romero FA; Wodka D; Kassick AJ; Dang Q; Gibson T; Cashion D; Zhou G; Chen Y; Zhang X; Zhang A; Li Y; Trujillo ME; Shao Q; Wu M; Xu S; He H; MacKenna D; Staunton J; Chapman KT; Weber A; Sebhat IK; Makara GM
    J Med Chem; 2017 Nov; 60(21):9040-9052. PubMed ID: 29035567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of MK-8318, a Potent and Selective CRTh2 Receptor Antagonist for the Treatment of Asthma.
    Huang X; Brubaker J; Zhou W; Biju PJ; Xiao L; Shao N; Huang Y; Dong L; Liu Z; Bitar R; Buevich A; Jung J; Peterson SL; Butcher JW; Close J; Martinez M; MacCoss RN; Zhang H; Crawford S; McCormick KD; Aslanian R; Nargund R; Correll C; Gervais F; Qiu H; Yang X; Garlisi C; Rindgen D; Maloney KM; Siliphaivanh P; Palani A
    ACS Med Chem Lett; 2018 Jul; 9(7):679-684. PubMed ID: 30034600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
    J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.